ROCKVILLE, Md. (MedPage Today) -- Advisers to the FDA voted today to recommend to the agency that two single-agent long-acting beta2 agonist inhalers be stripped of their asthma indications.
FDA Advisers Would End Asthma Indications for Two Long-Acting Be...Courtesy MedPage Today Allergy & Immunology Thu, 12/11/2008 - 15:06
ROCKVILLE, Md. (MedPage Today) -- Advisers to the FDA voted today to recommend to the agency that two single-agent long-acting beta2 agonist inhalers be stripped of their asthma indications. More related itemsFDA Advisers Consider Safety of Long-Acting Beta...
Traffic-Related Asthma Costs Underestimated (CME/CE)
Early Infant Weight Gain Tied to Asthma (CME/CE)
Finger Pulse Oximeter Octive Tech 300C with Hard...
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
|
Popular by tags WeekMonth |
Post new comment